Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | DrugBank | 薬物名（臨床試験情報から抽出） | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
|---|---|---|---|---|---|---|
| 1 |
Alnuctamab
(An asymmetric immunoglobulin G1 x CD3 T-cell bispecific monoclonal antibody) | 1件: Alnuctamab Alnuctamab | - | - | - | 1件: 49 49 💬
|
| 2 |
ARGX-119
(a fully humanized immunoglobulin gamma 1 that specifically targets and activates MuSK) | 1件: ARGX-119 ARGX-119 | - | - | - | 3件: 2 2, 3, 12 💬
|
| 3 |
Human immunoglobulin G
(Human immunoglobulin G) | 7件: Human Immunoglobulin Human Immunoglobulin; Human immunoglobulin G; HUMAN NORMAL IMMUNOGLOBULIN; Immune globulin; Immunoglobulin; IMMUNOGLOBULIN G; Intravenous Immunoglobulin | 1件: Globulin, immune
Globulin, immune
💬
| - | - | 4件: 14 14, 50, 63, 65 💬
|
| 4 |
OMS906
(Humanized immunoglobulin G4 monoclonal antibody directed against mannan-binding lectin-associated serine protease-3) | 1件: OMS906 OMS906 | - | - | - | 2件: 62 62, 223 💬
|
| 5 |
Talquetamab
(IMMUNOGLOBULIN G4) | 1件: Talquetamab Talquetamab | 1件: Talquetamab
Talquetamab
💬
| 1件: CD3E CD3E 💬
| 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 2件: 11 11, 28 💬
|
| 6 |
Telitacicept
(FUSION PROTEIN WITH HUMAN IMMUNOGLOBULIN G1) | 1件: Telitacicept Telitacicept | - | - | - | 14件: 11 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
|